In lithium metal batteries (LMBs), electrolytes composed of salts and organic solvents play a significant role in transporting Li+ ions and creating the surface film on Li-metal anodes. Herein, the effect of methyl acetate (MA) as a co-solvent is reported, which enables the facilitated Li+ transport and formation of a robust solid electrolyte interphase (SEI) on the Li-metal anode. The symmetrical Li//Li cell tests show remarkable cycle stability of MA-based electrolytes at 3 mA/cm2 without obvious voltage fluctuation. At 5 mA/cm2, the Li//Li cells in MA-based electrolytes can still run up to 110 h with lower overpotential, compared to the cell cycled with MA-free electrolytes. Furthermore, the LMBs consisting of the Li anode and LiNi0.8Co0.15Al0.05O2 (NCA) cathode deliver the high capacity (∼200 mA h/g), good cycling stability up to 300 cycles, excellent rate capability (10 C), and low self-discharging rates (8.5%) with MA-based electrolytes. Especially, the capacity of the Li//NCA cells with MA30 electrolytes at −35 °C is as high as 144 mA h/g, which is higher than that of the cells in MA-free electrolytes. It demonstrates that the MA is beneficial for the LMB operation at high rate and low temperature.

Miniaturization of immunoassays has numerous potential advantages over traditional ELISAs. Here we present a novel approach using patterned planar plates (PPPs). These 'wall-less' plates consist of a 16 × 24 array of 2 mm diameter hydrophilic regions surrounded by a hydrophobic polytetrafluoroethylene (PTFE) coating. Assays are performed by adding 2 μL droplets to the hydrophilic areas. These droplets are overlaid with an immiscible mixture of perfluorocarbon liquid (PFCL) that essentially eliminates evaporation. During wash steps, a thin film of PFCL covers the hydrophobic coating and prevents its wetting by wash buffer; as a result, the hydrophilic wells remain intact and inter-well cross-contamination is prevented. We compared the performance of three immunoassays using PPPs versus traditional 384-well ELISA plates. These included assays for soluble FcRH5 in human serum, SDF-1 in mouse serum, and human IgG in mouse plasma. The results show that the PPP assays were closely comparable to the ELISAs in terms of sensitivity, linearity of dilution, and sample quantitation. Moreover, the PPP assays were rapid to perform, easily adapted from ELISA protocols, and used 10- to 50-fold less sample and reagent volume as compared to 384- or 96-well plate ELISAs. As an additional advantage, PPPs conform to established microplate dimensional standards making them compatible with pre-existing equipment and workflows. PPPs therefore represent an attractive and broadly applicable approach to flexible miniaturization of plate-based immunochemical assays.

No abstract

No abstract

No abstract